These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17255294)

  • 21. Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma.
    Bielecka ZF; Czarnecka AM; Szczylik C
    Front Oncol; 2014; 4():194. PubMed ID: 25120953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of chemokine receptor 4 was associated with poor survival in renal cell carcinoma.
    Liu Q; Rexiati M; Yang Y; Wang WG; Azhati B; Saimaiti W; Wang YJ
    Med Oncol; 2014 Apr; 31(4):882. PubMed ID: 24554520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular events and biomarkers of wound healing.
    Shah JM; Omar E; Pai DR; Sood S
    Indian J Plast Surg; 2012 May; 45(2):220-8. PubMed ID: 23162220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma.
    Wang L; Chen W; Gao L; Yang Q; Liu B; Wu Z; Wang Y; Sun Y
    World J Surg Oncol; 2012 Oct; 10():212. PubMed ID: 23039915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kidney cancer pathology in the new context of targeted therapy.
    Allory Y; Culine S; de la Taille A
    Pathobiology; 2011; 78(2):90-8. PubMed ID: 21677472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance of renal cell carcinoma to sorafenib is mediated by potentially reversible gene expression.
    Zhang L; Bhasin M; Schor-Bardach R; Wang X; Collins MP; Panka D; Putheti P; Signoretti S; Alsop DC; Libermann T; Atkins MB; Mier JW; Goldberg SN; Bhatt RS
    PLoS One; 2011 Apr; 6(4):e19144. PubMed ID: 21559452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of percutaneous renal biopsy in the management of small renal masses.
    Wang R; Li AY; Wood DP
    Curr Urol Rep; 2011 Feb; 12(1):18-23. PubMed ID: 20949338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis.
    Wang L; Wang L; Yang B; Yang Q; Qiao S; Wang Y; Sun Y
    Clin Exp Metastasis; 2009; 26(8):1049-54. PubMed ID: 19859817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome.
    Arai E; Ushijima S; Fujimoto H; Hosoda F; Shibata T; Kondo T; Yokoi S; Imoto I; Inazawa J; Hirohashi S; Kanai Y
    Carcinogenesis; 2009 Feb; 30(2):214-21. PubMed ID: 19037089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue-based research in kidney cancer: current challenges and future directions.
    Signoretti S; Bratslavsky G; Waldman FM; Reuter VE; Haaga J; Merino M; Thomas GV; Pins MR; Libermann T; Gillespie J; Tomaszewski JE; Compton CC; Hruszkewycz A; Linehan WM; Atkins MB
    Clin Cancer Res; 2008 Jun; 14(12):3699-705. PubMed ID: 18559586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
    Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
    PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomics of renal cell cancer: the biology behind and the therapy ahead.
    Jones J; Libermann TA
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):685s-692s. PubMed ID: 17255294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma.
    Arsanious A; Bjarnason GA; Yousef GM
    Mol Cancer; 2009 Mar; 8():20. PubMed ID: 19291329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene signatures of progression and metastasis in renal cell cancer.
    Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
    Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA expression profiling of Xp11 renal cell carcinoma.
    Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
    Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.